2025年国际靶向抗癌治疗大会 ESMO TARGETED ANTICANCER THERAPIES CONGRESS 2025

◆ 会议时间：2025年3月3-5日
◆ 会议地点：法国 巴黎

◆ 会议简介：

2025年ESMO国际靶向抗癌治疗大会(TAT2025)将于2025年3月3-5日在法国巴黎举行，会议由欧洲肿瘤内科学会(ESMO)组织。靶向抗癌治疗(TAT)大会是ESMO官方年度会议，自2018年开始每年在欧洲举办。TAT会议是专注于讨论早期药物开发和转化研究的首要论坛，会议议题涵盖靶向药物、免疫肿瘤学和涉及此类药物的组合等方面。来自学术界和工业界的领导者、临床医生、研究人员和监管机构一起共同努力，加快开发新的抗癌治疗方法以提高患者的预后效果。

欧洲肿瘤内科学会（ESMO）成立于1975年，是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会，现在全球160多个国家和地区拥有超过25,000余名会员；ESMO致力于通过宣促进多学科的癌症护理，支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理，尽而为癌症患者提供最佳的护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

ESMO TARGETED ANTICANCER THERAPIES CONGRESS 2025

Date:
3 – 5 March 2025

Location:
Palais des Congrès de Paris, Paris, France

Plan your participation in the ESMO Targeted Anticancer Therapies Congress 2025, taking place from 3 to 5 March 2025 in Paris, France.

This multi-stakeholder forum brings together researchers, industry partners, investors, and regulatory bodies under the same roof, making the event essential for any professional involved in the development of new anticancer drugs.

We look forward to seeing you again in Paris in 2025, to share new data, promote collaboration and tackle challenges for accelerating the bench-to-bedside pathway to the benefit of our patients.

ESMO TAT 2025 Scientific Co-Chairs

Elena Garralda
Barcelona, Spain

Anastasios Stathis
Bellinzona, Switzerland

以下为上届会议信息，仅供参考！

摘要征文投稿：

Abstract submission deadline

点此提交摘要>>>Submit Abstract>>>

ESMO TAT 2024 Abstract Regulations>>>提交指南

Abstract submission categories

• Antibody-based therapies
• Cellular and gene therapies
• DNA damage repair and epigenetics
• Immunotherapy
• Kinase-targeting agents and cell signalling modulators
• Molecular profiling applications
• AI and digital therapeutics
• Methodological, financial and regulatory aspects
• Miscellaneous

Outcome notifications

Outcome notifications are expected to be made available to first authors by end-December 2023.

Presentation and publication of abstracts accepted

The ESMO TAT 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display sessions for review, discussion and questions. Presenting authors must be available for Q&A for one hour to represent their work.

All accepted abstracts will be published online only in the ESMO TAT 2024 Abstract Book, a supplement to the ESMO journal, ESMO Open.

Publication schedule for accepted abstracts

Abstracts accepted for presentation during ESMO TAT 2024 will be released online according to a schedule which will be available on the ESMO website in due course.

ESMO Merit Travel Grants

A limited number of ESMO Merit Travel Grants to ESMO TAT 2024 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO TAT 2024 Scientific Committee on a competitive basis from among the accepted abstracts.

注册费：

In-person participation includes:

• Participation in the scientific and educational live sessions with the possibility to interact with the expert panel
• Onsite networking opportunity with faculty and peers
• Entry to the Poster area
• Interaction with the Industry partners in the trade exhibition
• Participation in the Industry Satellite Symposia
• Access to the Post-event resources and sessions on-demand
• Coffee breaks and lunches

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

ESMO membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied.

* ESMO Members must be under 40 and in training to qualify for this fee.
** Applicable to individuals who are students only. At the time of application, a copy of the student card must be sent to registration@esmo.org.
*** Small Biotech: To be eligible for the small-biotech fee, your company must be actively developing oncology-related technology and not have any products on the market, as evidenced by information on the company’s website. Delegates claiming the small biotech fee must provide:

• Company name
• Website URL
• Company (not private) email address